Anastasia Christianson is a Vice President and Global Head of AI, ML, Analytics and Data at Pfizer. Anastasia obtained her Ph.D. in Biological Chemistry from the University of Pennsylvania followed by postdoctoral training at Harvard University in Cellular and Developmental Biology. She began her professional career at a small biotech company, DNX Biotherapeutics, Inc., before moving to AstraZeneca, then Zeneca. She has a broad range of experience in both Discovery and Clinical Development ranging from leading drug project teams, setting up Genomics and Bioinformatics in Wilmington, and establishing Biomedical Informatics in Clinical Development.
She has over 20 years of experience in the biotechnology and pharmaceutical industry working in both Discovery and Development leading projects, managing complex portfolios, driving change programs, identifying opportunities for strategic initiatives, and translating scientific and medical questions into innovative solutions. She has areas of particular strength include strategy development and implementation, translational medicine, biomedical and health informatics, evidence-based decision makings, data and decision science, and "Big Data" exploitation.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)